Clinical trials
Diabetes Mellitus trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
193 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2004 | 4 |
| 2005 | 4 |
| 2006 | 19 |
| 2007 | 13 |
| 2008 | 16 |
| 2009 | 18 |
| 2010 | 14 |
| 2011 | 11 |
| 2012 | 10 |
| 2013 | 10 |
| 2014 | 10 |
| 2015 | 6 |
| 2016 | 12 |
| 2017 | 10 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 9 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 154 |
| Terminated | 16 |
| Unknown status | 16 |
| Recruiting | 6 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 69 |
| AstraZeneca | 17 |
| Eli Lilly and Company | 11 |
| Takeda | 9 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | 5 |
| Bayer | 4 |
| Medanta, The Medicity, India | 4 |
| Phenomix | 4 |
| Allergan | 3 |
| Composite Interceptive Med Science | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 193 |
| Diabetes Mellitus, Type 2 | 123 |
| Diabetes Mellitus, Type 1 | 15 |
| Glucose Metabolism Disorders | 14 |
| Metabolic Diseases | 9 |
| Dyslipidemias | 8 |
| Endocrine System Diseases | 7 |
| Hypertension | 6 |
| Insulin Resistance | 5 |
| Obesity | 5 |
Trials
Showing 76 to 100 of 193. Each trial links to its page on Pharma Observatory.
93 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.